Genome-wide DNA Methylation Analysis Using Massively Parallel Sequencing Technologies

Seminars in Hematology

Volumn 50, Issue 1, 2013, Pages 70-77

  Suzuki, Masako ^a   Greally, John M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBOXYLCYTOSINE; 5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; BISULFITE; CYTOSINE; CYTOSINE DERIVATIVE; DNA; UNCLASSIFIED DRUG; URACIL;

ARTICLE; BISULFITE REACTION BASED ASSAY; CPG ISLAND; DNA FRAGMENTATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENETIC ANALYSIS; GENETIC PROCEDURES; GENOME ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MASSIVELY PARALLEL SEQUENCING; MOLECULAR SIZE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DNA; DNA FINGERPRINTING; DNA METHYLATION; EPIGENESIS, GENETIC; GENOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS;

EID: 84875290402     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.01.002     Document Type: Article

References (66)

1. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057-1068.
2. Chen S.S., Raval A., Johnson A.J., et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2009, 106:13433-13438.
3. Dwivedi R.S., Herman J.G., McCaffrey T.A., Raj D.S. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011, 79:23-32.
4. Zhou L., Opalinska J., Sohal D., et al. Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q. J Biol Chem 2011, 286:25211-25223.
5. Pascual M., Suzuki M., Isidoro-Garcia M., et al. Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma. Epigenetics 2011, 6.
6. Figueroa M.E., Lugthart S., Li Y., et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010, 17:13-27.
7. Stitzel M.L., Sethupathy P., Pearson D.S., et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab 2010, 12:443-455.
8. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96:8681-8686.
9. Toyota M., Ahuja N., Suzuki H., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999, 59:5438-5442.
10. + T cells from patients with systemic lupus erythematosus. Epigenetics 2011, 6:593-601.
11. Lister R., Pelizzola M., Dowen R.H., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
12. Xie W., Barr C.L., Kim A., et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 2012, 148:816-831.
13. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(Suppl):245-254.
14. Smith Z.D., Chan M.M., Mikkelsen T.S., et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 2012, 484:339-344.
15. Chapman V., Forrester L., Sanford J., Hastie N., Rossant J. Cell lineage-specific undermethylation of mouse repetitive DNA. Nature 1984, 307:284-286.
16. Shiota K., Kogo Y., Ohgane J., et al. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 2002, 7:961-969.
17. Monk M., Boubelik M., Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 1987, 99:371-382.
18. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
19. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
20. Ueki T., Toyota M., Sohn T., et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000, 60:1835-1839.
21. Acosta D., Suzuki M., Connolly D., et al. DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis. Mamm Genome 2011, 22:249-259.
22. Akiyama Y., Watkins N., Suzuki H., et al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 2003, 23:8429-8439.
23. Gebhard C., Schwarzfischer L., Pham T.H., et al. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006, 66:6118-6128.
24. Ferguson-Smith A.C., Sasaki H., Cattanach B.M., Surani M.A. Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 1993, 362:751-755.
25. Ball M.P., Li J.B., Gao Y., et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 2009, 27:361-368.
26. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008, 9:465-476.
27. Suzuki M., Oda M., Ramos M.P., et al. Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome. Genome Res 2011, 21:1833-1840.
28. Zilberman D., Gehring M., Tran R.K., Ballinger T., Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 2007, 39:61-69.
29. Down T.A., Rakyan V.K., Turner D.J., et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 2008, 26:779-785.
30. Brinkman A.B., Simmer F., Ma K., Kaan A., Zhu J., Stunnenberg H.G. Whole-genome DNA methylation profiling using MethylCap-seq. Methods 2010, 52:232-236.
31. Serre D., Lee B.H., Ting A.H. MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res 2010, 38:391-399.
32. Hayatsu H., Wataya Y., Kai K., Iida S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry 1970, 9:2858-2865.
33. Hayatsu H., Wataya Y., Kazushige K. The addition of sodium bisulfite to uracil and to cytosine. J Am Chem Soc 1970, 92:724-726.
34. Kai K., Tsuruo T., Hayatsu H. The effect of bisulfite modification on the template activity of DNA for DNA polymerase I. Nucleic Acids Res 1974, 1:889-899.
35. Frommer M., McDonald L.E., Millar D.S., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992, 89:1827-1831.
36. Meissner A., Gnirke A., Bell G.W., Ramsahoye B., Lander E.S., Jaenisch R. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res 2005, 33:5868-5877.
37. Meissner A., Mikkelsen T.S., Gu H., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454:766-770.
38. Lister R., O'Malley R.C., Tonti-Filippini J., et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 2008, 133:523-536.
39. Cokus S.J., Feng S., Zhang X., et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008, 452:215-219.
40. Brunner A.L., Johnson D.S., Kim S.W., et al. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res 2009, 19:1044-1056.
41. Oda M., Glass J.L., Thompson R.F., et al. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res 2009, 37:3829-3839.
42. Li J., Gao F., Li N., et al. An improved method for genome wide DNA methylation profiling correlated to transcription and genomic instability in two breast cancer cell lines. BMC Genom 2009, 10:223.
43. Suzuki M., Jing Q., Lia D., Pascual M., McLellan A., Greally J.M. Optimized design and data analysis of tag-based cytosine methylation assays. Genome Biol 2010, 11:R36.
44. Ogoshi K., Hashimoto S., Nakatani Y., et al. Genome-wide profiling of DNA methylation in human cancer cells. Proc Natl Acad Sci U S A 2011, 98:280-287.
45. Colaneri A., Staffa N., Fargo D.C., et al. Expanded methyl-sensitive cut counting reveals hypomethylation as an epigenetic state that highlights functional sequences of the genome. Proc Natl Acad Sci U S A 2011, 108:9715-9720.
46. Bernstein B.E., Stamatoyannopoulos J.A., Costello J.F., et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 2010, 28:1045-1048.
47. Tahiliani M., Koh K.P., Shen Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
48. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
49. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
50. Langemeijer S.M., Aslanyan M.G., Jansen J.H. TET proteins in malignant hematopoiesis. Cell Cycle 2009, 8:4044-4048.
51. Nestor C.E., Ottaviano R., Reddington J., et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 2012, 22:467-477.
52. Ruzov A., Tsenkina Y., Serio A., et al. Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res 2011, 21:1332-1342.
53. Haffner M.C., Chaux A., Meeker A.K., et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-637.
54. Ficz G., Branco M.R., Seisenberger S., et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
55. Yang H., Liu Y., Bai F., et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2012, 32(5):663-669. 31.
56. Kudo Y., Tateishi K., Yamamoto K., et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012, 103:670-676.
57. Ito S., Shen L., Dai Q., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
58. He Y.F., Li B.Z., Li Z., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
59. Booth M.J., Branco M.R., Ficz G., et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336(6083):934-937.
60. Nestor C., Ruzov A., Meehan R., Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 2010, 48:317-319.
61. Huang Y., Pastor W.A., Shen Y., Tahiliani M., Liu D.R., Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
62. Ichiyanagi K. Inhibition of MspI cleavage activity by hydroxymethylation of the CpG site: a concern for DNA modification studies using restriction endonucleases. Epigenetics 2012, 7:131-136.
63. Salbert G., Weber M. Tracking genomic hydroxymethylation by the base. Nat Methods 2012, 9:45-46.
64. Yu M., Hon G.C., Szulwach K.E., et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149(6):1368-1380.
65. Figueroa M.E., Abdel-Wahab O., Lu C., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
66. Gaidzik V.I., Paschka P., Spath D., et al. TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML Study Group. J Clin Oncol 2012, 30:1350-1357.